Vote Scores
Filings read through

Rhythm Pharmaceuticals, Inc.: how funds voted at the meeting of 24 Jun 2025

Ticker
RYTM
Meeting
Season
year to 30 June 2025
Filers reporting
375
Ballot items
4

375 filers on Form N-PX reported votes at the Rhythm Pharmaceuticals, Inc. meeting of 24 Jun 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Rhythm Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 49.0% of the reported votes are for. 130 filers withheld from or voted against at least one nominee.

    506 vote records from 147 filers. 23 of the 146 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 42 fund families
    • For 6
    • Abstain or withhold 11
    • Split or no vote 25
    • Against management 11
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    526 vote records from 374 filers. 228 of the 363 filers that marked the item voted against management. 11 filers gave no management mark.

    • Positions of 44 fund families
    • For 17
    • Against 27
    • Against management 27
  3. Item 3: Audit-related items (auditor ratification)

    242 vote records from 147 filers. 3 of the 146 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 42 fund families
    • For 42
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    459 vote records from 146 filers. 13 of the 145 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 42 fund families
    • For 29
    • Against 6
    • Split or no vote 7
    • Against management 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rhythm Pharmaceuticals, Inc., meeting of 24 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
American CenturyAgainst, against managementFor
BlackRock and iSharesAgainst, against managementFor
BNY MellonForFor
Brighthouse FundsAgainst, against managementFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementNo report
DWSAgainst, against managementFor
EquitableAgainst, against managementFor
Federated HermesForFor
FidelityForFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XAgainst, against managementFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
Harbor FundsAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
Lord AbbettForFor
MassMutualForFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementFor
Neuberger BermanAgainst, against managementFor
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsAgainst, against managementFor
PGIM and PrudentialForFor
PrincipalAgainst, against managementFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementFor
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceForFor
TransamericaForFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VoyaForFor

Questions

How many filers reported votes at the Rhythm Pharmaceuticals, Inc. meeting?
375 Form N-PX filers reported votes at the meeting of 24 Jun 2025. On say-on-pay, 228 of 363 filers that marked the item voted against management (62.8%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Rhythm Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rhythm Pharmaceuticals, Inc. with a meeting date within three days of 24 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .